Literature DB >> 26561470

Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study.

Lei Liu1,2, Qi-Shun Zhang2, Ling-Hui Pan3, Jian-Hong Zhong4,5, Zhen-Ming Qin6, Yan-Yan Wang1, Hong-Gui Qin1, Wen-Feng Gong1,7, Lu-Nan Qi1,7, Bang-De Xiang1,7, Le-Qun Li8,9.   

Abstract

Official guidelines group together all cases of solitary hepatocellular carcinoma (HCC) without macroscopic vascular invasion, regardless of tumor size. Here, we examined whether this is justified based on overall survival (OS) after hepatic resection (HR). Patients with newly diagnosed solitary HCC treated by initial HR from January 2004 to October 2013 were classified into six groups based on tumor size (in 2-cm increments). Combining adjacent categories with similar OS led to three groups: ≤5 cm (n = 426), >5 and ≤8 cm (n = 229), and >8 cm (n = 202). Among all patients, median survival time was 62 months, and OS was 95 % at 1 year, 73 % at 3 years, and 54 % at 5 years. Patients in the ≤5 cm group showed significantly higher OS (P < 0.001) and lower tumor recurrence (P = 0.004) than those in the >5 and ≤8 cm group, who in turn showed significantly higher OS (P = 0.003) and lower tumor recurrence (P = 0.021) than those in the >8 cm group. Our results suggest that patients with solitary HCC should be subclassified based on tumor size for more accurate prognosis. We propose defining solitary HCC tumors >5 and ≤8 cm as "large" and tumors >8 cm as "huge".

Entities:  

Keywords:  Hepatic resection; Hepatocellular carcinoma; Overall survival; Tumor size

Mesh:

Year:  2015        PMID: 26561470     DOI: 10.1007/s13277-015-4387-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

2.  Reply to Letter: "A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group": When the Study Setting "Ignores" the Patients.

Authors:  Guido Torzilli; Jacques Belghiti; Norihiro Kokudo; Tadatoshi Takayama; Lorenzo Capussotti; Gennaro Nuzzo; Jean-Nicolas Vauthey; Michael A Choti; Eduardo De Santibanes; Matteo Donadon; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

3.  Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.

Authors:  Han Zhang; Shou-Xin Yuan; Shu-Yang Dai; Jin-Min Zhang; Xing Huang; Chong-De Lu; Jun-Hua Lu; Fu-Quan Wu; Wan Yee Lau; Meng-Chao Wu; Tian Yang; Feng Shen
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

4.  Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; John Wong
Journal:  J Am Coll Surg       Date:  2002-05       Impact factor: 6.113

5.  Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.

Authors:  Lian-Yue Yang; Feng Fang; Di-Peng Ou; Wei Wu; Zhi-Jun Zeng; Fan Wu
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

6.  Chinese experience with hepatectomy for huge hepatocellular carcinoma.

Authors:  X P Chen; F Z Qiu; Z D Wu; B X Zhang
Journal:  Br J Surg       Date:  2004-03       Impact factor: 6.939

7.  Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.

Authors:  S Truant; E Boleslawski; A Duhamel; A-F Bouras; A Louvet; C Febvay; E Leteurtre; G Huet; P Zerbib; S Dharancy; M Hebbar; F-R Pruvot
Journal:  Eur J Surg Oncol       Date:  2012-08-03       Impact factor: 4.424

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

9.  Outcomes of hepatic resection for a single large hepatocellular carcinoma.

Authors:  Yong Beom Cho; Kuhn Uk Lee; Hae Won Lee; Eung-Ho Cho; Sung-Hoon Yang; Jai Young Cho; Nam-Joon Yi; Kyung-Suk Suh
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

10.  Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Authors:  Jian-Hong Zhong; Bang-De Xiang; Wen-Feng Gong; Yang Ke; Qin-Guo Mo; Liang Ma; Xing Liu; Le-Qun Li
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  4 in total

1.  Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.

Authors:  Junyi Shen; Linye He; Chuan Li; Tianfu Wen; Weixia Chen; Changli Lu; Lvnan Yan; Bo Li; Jiayin Yang
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

2.  Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameter.

Authors:  Jian-Hong Zhong; Ling-Hui Pan; Yan-Yan Wang; Alessandro Cucchetti; Tian Yang; Xue-Mei You; Liang Ma; Wen-Feng Gong; Bang-De Xiang; Ning-Fu Peng; Fei-Xiang Wu; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Reclassification of tumor size for solitary HBV-related hepatocellular carcinoma by minimum p value method: a large retrospective study.

Authors:  Hongzhi Liu; Yuan Yang; Chuanchun Chen; Lei Wang; Qizhen Huang; Jianxing Zeng; Kongying Lin; Yongyi Zeng; Pengfei Guo; Weiping Zhou; Jingfeng Liu
Journal:  World J Surg Oncol       Date:  2020-07-24       Impact factor: 2.754

4.  A simple prognostic score system predicts the prognosis of solitary large hepatocellular carcinoma following hepatectomy.

Authors:  Jun-Yi Shen; Chuan Li; Tian-Fu Wen; Lv-Nan Yan; Bo Li; Wen-Tao Wang; Jia-Yin Yang; Ming-Qing Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.